메뉴 건너뛰기
Clinical Infectious Diseases
Volumn 49, Issue 9, 2009, Pages 1457-1458
Serum cross-reactivity with aspergillus galactomannan and cryptococcal antigen during fatal disseminated trichosporon dermatis infection
Author keywords

[No Author keywords available]
Indexed keywords

CASPOFUNGIN; FUNGUS ANTIGEN; GALACTOMANNAN; VORICONAZOLE;
EID: 72849126707     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/644499     Document Type: Letter
Times cited : (25)
References (5)
  • 1
    • 66949176205 scopus 로고    scopus 로고
    • Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at amedical center in Taiwan
    • Ruan S-Y, Chien J-Y, Hsueh P-R. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at amedical center in Taiwan. Clin Infect Dis 2009; 49:e11-7.
    • (2009) Clin Infect Dis , vol.49
    • Ruan, S.-Y.1    Chien, J.-Y.2    Hsueh, P.-R.3
  • 2
    • 46249126149 scopus 로고    scopus 로고
    • Revised definitions of invasive fungal disease from the european organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and the infectious diseases mycoses study group (EORTC/MSG) consensus group
    • De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and the Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46:1813-1821
    • (2008) Clin Infect Dis , vol.46 , pp. 1813-1821
    • De Pauw, B.1    Walsh, T.J.2    Donnelly, J.P.3
  • 3
    • 9644284471 scopus 로고    scopus 로고
    • Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy
    • Maertens J, Raad I, Petrikkos G, et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004;39:1563-1571
    • (2004) Clin Infect Dis , vol.39 , pp. 1563-1571
    • Maertens, J.1    Raad, I.2    Petrikkos, G.3
  • 4
    • 0028924765 scopus 로고
    • Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity
    • Lyman CA, Devi SJ, Nathanson J, Frasch CE, Pizzo PA,Walsh TJ. Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity. J Clin Microbiol 1995;33:126-130
    • (1995) J Clin Microbiol , vol.33 , pp. 126-130
    • Lyman, C.A.1    Devi, S.J.2    Nathanson, J.3    Frasch, C.E.4    Pizzo, P.A.5    Walsh, T.J.6
  • 5
    • 20444435083 scopus 로고    scopus 로고
    • Cryptococcus neoformans galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus galactomannan
    • Dalle F, Charles PE, Blanc K, et al. Cryptococcus neoformans galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus galactomannan. J Clin Microbiol 2005; 43:2929-2931
    • (2005) J Clin Microbiol , vol.43 , pp. 2929-2931
    • Dalle, F.1    Charles, P.E.2    Blanc, K.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.